Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces the appointment of Dr. Michael Gibson as its new Chief ...
At times the medical profession and the world of healthcare come across as a sterile science preoccupied with the technical explanation of an ailment rather than the actual person afflicted with it.
Dr. Robert W. Gibson, a seminal figure for more than three decades at the Sheppard and Enoch Pratt Hospital where he oversaw the desegregation of its facilities, ended its bankruptcy and extended it ...